Article
Risk factors associated with the acquisition of linezolid-resistant Enterococcus faecalis
2019-09-12
Abstract excerpt
<title>Abstract</title> <p>Background Linezolid is used to treat vancomycin-resistant enterococcal infections. Vancomycin-resistant and -susceptible Enterococcus faecalis can develop resistance to linezolid in clinical settings with high linezolid consumption. Linezolid-resistant E. faecalis (LREF) has emerged as a major nosocomial pathogen in our hospital, in which linezolid use is considerable.Aim To define ris...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 48cc4fc2-7f80-51a5-966d-578494047a99
- DOI
- 10.21203/rs.2.14339/v1
